Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Filtered Value Type Gene Rank description green Interaction Map Network Comparison Type red network_comparison
Results: HTML CSV LaTeX
Showing element 51 to 100 of 77072 in total
Filtered: 0
Value Type: Measured

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fk506-binding protein 6 (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (36 kda fk506 binding protein) (fkbp- 36) (immunophilin fkbp36). [source:swissprot;acc:o75344]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
115.385\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8.11997\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.21\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3953.32\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2961.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
992.25\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12125.1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
10817.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1308\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6.50325\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
130.512\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
20.0687\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
59\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho gdp-dissociation inhibitor 1 (rho gdi 1) (rho-gdi alpha). [source:swissprot;acc:p52565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16295.1\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17235.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
940.4\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2740.13\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
485.286\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.64642\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
myotubularin related protein 8. [source:refseq;acc:nm\_017677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4823.8\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3888.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
935.2\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (cybs) (succinate-ubiquinone reductase membrane anchor subunit) (qps2) (cii-4) (succinate dehydrogenase complex subunit d) (succinate-ubiquinone oxidoreductase cytochrome b small subunit). [source:swissprot;acc:o14521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
156\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15.6\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6685.11\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
7981.68\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1296.57\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7572.88\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
8852.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1279.52\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, lysine deficient 3. [source:refseq;acc:nm\_020922]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
704.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.636\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
vps10 domain-containing receptor sorcs1 precursor (hsorcs). [source:swissprot;acc:q8wy21]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9808\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
8926.33\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
881.67\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba271b5.1 (similar to ribosomal protein s7). [source:sptrembl;acc:q9h1s9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12473\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
11223\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1250\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ena/vasodilator stimulated phosphoprotein-like protein (ena/vasp-like protein). [source:swissprot;acc:q9ui08]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5837.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
4959.42\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
878.41\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.8103\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
14167\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15411.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1244.3\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
camp-regulated phosphoprotein 19 (arpp-19) [contains: camp-regulated phosphoprotein 16 (arpp-16)]. [source:swissprot;acc:p56211]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.21053\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
58\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
801\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2804\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1211\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
662\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.3268\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2407.27\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3205.98\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
798.71\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
139\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
570\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.10072\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
8200000\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7608\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
8763\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1155\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3169.35\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
2376\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
793.35\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
434.911\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
111.278\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.90833\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3321.82\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4088.01\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
766.19\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily d member 1 (swi/snf complex 60 kda subunit) (brg1- associated factor 60a). [source:swissprot;acc:q96gm5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5690.63\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
6804.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1114.25\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 10 (syn10). [source:swissprot;acc:o60499]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17.6611\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
118.878\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6.73106\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carbohydrate (n-acetylglucosamine 6-o) sulfotransferase 6; macular dystrophy, corneal, 1; carbohydate sulfotransferase 6; corneal n-acetylglucosamine 6-sulfotransferase. [source:refseq;acc:nm\_021615]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3700000\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lysozyme c-1 (1,4-beta-n-acylmuramidase c, ec 3.2.1.17). [source:refseq;acc:nm\_032517]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6000000\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorbitol dehydrogenase (ec 1.1.1.14) (l-iditol 2-dehydrogenase). [source:swissprot;acc:q00796]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4100.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4821.65\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
721.41\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 135 kda subunit (tafii-135) (tafii135) (tafii-130) (tafii130). [source:swissprot;acc:o00268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
30022.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
31122\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1099.6\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carbohydrate (n-acetylglucosamine-6-o) sulfotransferase 2; carbohydrate (chondroitin 6/keratan) sulfotransferase 2. [source:refseq;acc:nm\_004267]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3700000\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5584.69\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
6302.92\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
718.23\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5540.2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
6596.23\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1056.03\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
59\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin z precursor (ec 3.4.22.-) (cathepsin x) (cathepsin p). [source:swissprot;acc:q9ubr2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
493\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.2013\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2208.1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3233.86\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1025.76\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
158\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 3 (wasp-family protein member 3) (verprolin homology domain-containing protein 3). [source:swissprot;acc:q9upy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4550.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
5202.89\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
652.25\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
459.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
917.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
39.8063\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.6208\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.15402\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.22297\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5220.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4589.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
630.82\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/